Publication | Open Access

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189

Protocol-specified Final AnalysisPrognostic BiomarkersUrologyOncologyMetastatic Nonsquamous NsclcClinical TrialsImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentMedicineRadiation OncologyHealth Sciences